Development of a specialty medication clinical dashboard to improve tumor necrosis factor-&#945; inhibitor safety and adherence monitoring.

Hu, Anna M; Pepin, Marc J; Hashem, Mohamed G; Britt, Rachel B; Britnell, Sara R; Bryan, William E; Brown, Jamie N

Development of a specialty medication clinical dashboard to improve tumor necrosis factor-α inhibitor safety and adherence monitoring.

Hu, Anna M; Pepin, Marc J; Hashem, Mohamed G; Britt, Rachel B; Britnell, Sara R; Bryan, William E; Brown, Jamie N.

Afiliación

Hu AM; Pharmacy Department, Durham Veterans Affairs Health Care System, Durham, NC, USA.
Pepin MJ; Pharmacy Department, Memorial Hermann Health System, Houston, TX, USA.
Hashem MG; Pharmacy Department, Geriatric Research Education and Clinical Center, Durham Veterans Affairs Health Care System, Durham, NC, USA.
Britt RB; Pharmacy Department, Durham Veterans Affairs Health Care System, Durham, NC, USA.
Britnell SR; Pharmacy Department, Durham Veterans Affairs Health Care System, Durham, NC, USA.
Bryan WE; Pharmacy Department, Durham Veterans Affairs Health Care System, Durham, NC, USA.
Brown JN; Pharmacy Department, Geriatric Research Education and Clinical Center, Durham Veterans Affairs Health Care System, Durham, NC, USA.

Am J Health Syst Pharm ; 79(8): 683-688, 2022 04 01.

Article en En | MEDLINE | ID: mdl-34864858

Asunto(s)

Administración del Tratamiento Farmacológico; Farmacéuticos; Inhibidores del Factor de Necrosis Tumoral; Factor de Necrosis Tumoral alfa; Presentación de Datos; Humanos; Factores Inmunológicos; Cumplimiento de la Medicación; Programas de Monitoreo de Medicamentos Recetados; Mejoramiento de la Calidad; Inhibidores del Factor de Necrosis Tumoral/administración & dosificación; Inhibidores del Factor de Necrosis Tumoral/efectos adversos; Factor de Necrosis Tumoral alfa/antagonistas & inhibidores

Palabras clave

adverse drug reaction; clinical dashboard; medication adherence; population health management; specialty medication; tumor necrosis factor-α inhibitors

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacéuticos / Factor de Necrosis Tumoral alfa / Administración del Tratamiento Farmacológico / Inhibidores del Factor de Necrosis Tumoral Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Am J Health Syst Pharm Asunto de la revista: FARMACIA / HOSPITAIS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google